Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease

被引:22
|
作者
Zhu, Kai [1 ,2 ]
Li, Jun [1 ,2 ]
Wang, Yulin [1 ,2 ]
Lai, Hao [1 ,2 ]
Wang, Chunsheng [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200032, Peoples R China
[2] Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China
基金
美国国家科学基金会;
关键词
IRON-OXIDE NANOPARTICLES; GENE DELIVERY; GROWTH-FACTOR; PLASMID DNA; IN-VIVO; TRACKING; TRANSFECTION; RETENTION; CYTOTOXICITY; EFFICIENCY;
D O I
10.1155/2016/1384658
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cell therapy has attracted increasing attention as a promising treatment strategy for cardiac repair in ischemic heart disease. Nanoparticles (NPs), with their superior physical and chemical properties, have been widely utilized to assist stem cell therapy. With the help of NPs, stem cells can be genetically engineered for enhanced paracrine profile. To further understand the fate and behaviors of stem cells in ischemic myocardium, imaging NPs can label stem cells and be tracked in vivo under multiple modalities. Besides that, NPs can also be used to enhance stem cell retention in myocardium. These facts have raised efforts on the development of more intelligent and multifunctional NPs for cellular application. Herein, an overview of the applications of NPs-assisted stem cell therapy is given. Key issues and future prospects are also critically addressed.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier
    Poomani, Merlin Sobia
    Mariappan, Iyyadurai
    Perumal, Ramachandran
    Regurajan, Rathika
    Muthan, Krishnaveni
    Subramanian, Venkatesh
    GLOBAL HEART, 2022, 17 (01)
  • [22] Stem Cell Therapy for Heart Disease
    Puliafico, Shannon B.
    Penn, Marc S.
    Silver, Kevin H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (10) : 1353 - 1363
  • [23] Stem Cell Therapy for Heart Disease
    Shannon B. Puliafico
    Marc S. Penn
    Kevin H. Silver
    Journal of General Internal Medicine, 2013, 28 : 1353 - 1363
  • [24] Enhanced Cell Therapy for Ischemic Heart Disease
    Bonaros, Nikolaos
    Rauf, Rauend
    Schachner, Thomas
    Laufer, Guenther
    Kocher, Alfred
    TRANSPLANTATION, 2008, 86 (09) : 1151 - 1160
  • [25] Stem Cell Therapy for the Treatment of Acute Myocardial Infarction and Chronic Ischemic Heart Disease
    Donndorf, Peter
    Strauer, Bodo-Eckhard
    Haverich, Axel
    Steinhoff, Gustav
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2013, 14 (01) : 12 - 19
  • [26] Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart Disease
    Hyun-Min Cho
    Je-Yoel Cho
    Stem Cell Reviews and Reports, 2021, 17 : 1264 - 1279
  • [27] Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart Disease
    Cho, Hyun-Min
    Cho, Je-Yoel
    STEM CELL REVIEWS AND REPORTS, 2021, 17 (04) : 1264 - 1279
  • [28] The Challenges of Stem Cell Treatment in Ischemic Heart Disease
    Kornowski, Ran
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 73 (03) : 289 - 290
  • [29] Mesoporous silica nanoparticles-assisted ruthenium(Ⅱ) complexes for live cell staining
    Jia Wen
    Hui Yan
    Pengyi Xia
    Yongqian Xu
    Hongjuan Li
    Shiguo Sun
    Science China(Chemistry), 2017, (06) : 799 - 805
  • [30] Bipyramidal gold nanoparticles-assisted plasmonic photothermal therapy for ocular applications
    Alba-Molina, David
    Cano, Manuel
    Blanco-Blanco, Mario
    Ortega-Llamas, Laura
    Jimenez-Gomez, Yolanda
    Gonzalez-Lopez, Ana
    Perez-Perdomo, Mayelin
    Camacho, Luis
    Giner-Casares, Juan J.
    Gonzalez-Andrades, Miguel
    JOURNAL OF MATERIALS CHEMISTRY B, 2025, 13 (09) : 3000 - 3010